Bionano Genomics Inc (BNGO)
0.7944
+0.03
(+4.44%)
USD |
NASDAQ |
Apr 23, 16:00
0.8052
+0.01
(+1.36%)
After-Hours: 07:52
Bionano Genomics Total Liabilities (Quarterly): 118.25M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 118.25M |
| September 30, 2023 | 62.90M |
| June 30, 2023 | 56.62M |
| March 31, 2023 | 60.66M |
| December 31, 2022 | 58.10M |
| September 30, 2022 | 41.96M |
| June 30, 2022 | 36.82M |
| March 31, 2022 | 37.03M |
| December 31, 2021 | 39.98M |
| September 30, 2021 | 18.09M |
| June 30, 2021 | 10.94M |
| March 31, 2021 | 22.14M |
| December 31, 2020 | 25.37M |
| Date | Value |
|---|---|
| September 30, 2020 | 26.72M |
| June 30, 2020 | 21.37M |
| March 31, 2020 | 23.32M |
| December 31, 2019 | 26.59M |
| September 30, 2019 | 26.59M |
| June 30, 2019 | 26.56M |
| March 31, 2019 | 23.68M |
| December 31, 2018 | 14.67M |
| September 30, 2018 | 15.43M |
| June 30, 2018 | 75.37M |
| March 31, 2018 | 70.48M |
| December 31, 2017 | 60.37M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
10.94M
Minimum
Jun 2021
118.25M
Maximum
Dec 2023
38.95M
Average
26.72M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp | 2.837B |
| Azenta Inc | 380.65M |
| Harvard Bioscience Inc | 64.29M |
| Akoya Biosciences Inc | 126.60M |
| Singular Genomics Systems Inc | 86.46M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 214.40M |
| Shareholders Equity (Quarterly) | 96.16M |
| Debt to Equity Ratio | 0.7259 |
| Current Ratio | 1.401 |
| Net Debt Paydown Yield | -16.14% |